Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 48, 2009, Pages 20429-20434

  Bogunovic, Dusan ^a   O'Neill, David W ^a   Belitskaya Levy, Ilana ^a   Vacic, Vladimir ^b   Yu, Yi Lo ^a,c   Adams, Sylvia ^a   Darvishian, Farbod ^a   Berman, Russell ^a   Shapiro, Richard ^a   Pavlick, Anna C ^a   Lonardi, Stefano ^b   Zavadil, Jiri ^a   Osman, Iman ^a   Bhardwaj, Nina ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b University of California Riverside   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Gene expression analysis; Immune response; TNM staging; Tumor infiltrating leukocytes

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD3D ANTIGEN; CHEMOKINE RECEPTOR CCR7; CXCL13 CHEMOKINE; CYCLIN DEPENDENT KINASE 2; GRANZYME; GRANZYME K; GRAPEVINE RETROTRANSPOSON 1; INDUCIBLE T LYMPHOCYTE COSTIMULATOR; LYMPHOCYTE ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; NUCLEOLAR AND SPINDLE ASSOCIATED PROTEIN 1; PHOSPHODIESTERASE; PHOSPHODIESTERASE IVD; PROTEIN; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; T CELL RECEPTOR ASSOCIATED TRANSMEMBRANE ADAPTOR 1; T LYMPHOCYTE RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOSURVEILLANCE; MALE; MELANOMA; METASTASIS; MITOSIS INDEX; PREDICTION; PRIORITY JOURNAL; SPINDLE POLE BODY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MITOTIC INDEX; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 73949140415     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905139106     Document Type: Article

References (33)

1. Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445:851-857.
2. Thompson JF, Scolyer RA, Kefford RF (2005) Cutaneous melanoma. Lancet 365:687-701.
3. Fecher LA, Cummings SD, Keefe MJ, Alani RM (2007) Toward amolecular classification of melanoma. J Clin Oncol 25:1606-1620.
4. Balch CM, Soong SJ (2008) Predicting outcomes in metastatic melanoma. J Clin Oncol 26:168-169.
5. Golub TR, et al. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286:531-537.
6. Mills K (2008) Gene expression profiling for the diagnosis and prognosis of acute myeloid leukaemia. Front Biosci 13:4605-4616.
7. van't Veer LJ, Bernards R (2008) Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 452:564-570.
8. Henry NL, Hayes DF (2007) Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancer. Oncology (Williston Park) 21: 1301-1309; discussion 1311, 1314-1319.
9. Nahleh ZA (2008) Molecularly targeted therapy in breast cancer: The new generation. Recent Pat Anticancer Drug Discov 3:100-110.
10. Haqq C, et al. (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102:6092-6097.
11. Jaeger J, et al. (2007) Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res 13:806-815.
12. Tusher VG, Tibshirani R, ChuG(2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
13. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 57: 289-300.
14. Mardia KV, Kent JT, Bibby JM (1979) Multivariate Analysis (Academic Press, New York).
15. Hofling H, Tibshirani R (2008) A study of pre-validation. Annals of Applied Statistics 2:643-664.
16. Tibshirani RJ, Efron B (2002) Pre-validation and inference in microarrays. Stat Appl Genet Mol Biol 1, Article1.
17. Brown MP, et al. (2000) Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA 97:262-267.
18. Furey TS, et al. (2000) Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16:906-914.
19. John T, et al. (2008) Predicting clinical outcome through molecular profiling in stage III melanoma. Clin Cancer Res 14:5173-5180.
20. Piras F, et al. (2005) The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer 104:1246-1254.
21. Sato E, et al. (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102:18538-18543.
22. Galon J, et al. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960-1964.
23. Clemente CG, et al. (1996) Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303-1310.
24. Mihm MC, Jr, Clemente CG, CascinelliN (1996) Tumor infiltrating lymphocytes in lymph node melanomametastases: A histopathologic prognostic indicator and an expression of local immune response. Lab Invest 74:43-47.
25. Dave SS, et al. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351:2159-2169.
26. Chen H, et al. (2009) Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues. Proc Natl Acad Sci USA 106:2729-2734.
27. Attis MG, Vollmer RT (2007) Mitotic rate in melanoma: A reexamination. Am J Clin Pathol 127:380-384.
28. Francken , et al. (2004) The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 11:426-433.
29. Balch CM, Gershenwald JE, Soong S-J, Sober A, Kirkwood J (2009) in Cutaneous Melanoma, ed Balch CM, Houghton A, Sober A, and Soong S-J (Quality Medical Publishing, St. Louis).
30. Box GE, Cox DR (1964) An analysis of transformations. J R Stat Soc B 26:211-246.
31. RDC Team (2008) R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna).
32. Pavlidis P, Lewis DP, Noble WS (2002) Exploring gene expression data with class scores. Pac Symp Biocomput, 474-485.
33. Irizarry RA, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.